tiprankstipranks
Trending News
More News >
IXICO PLC (GB:IXI)
LSE:IXI
Advertisement

IXICO plc (IXI) Price & Analysis

Compare
12 Followers

IXI Stock Chart & Stats


IXICO plc News

IXI FAQ

What was IXICO PLC’s price range in the past 12 months?
IXICO PLC lowest share price was 6.60p and its highest was 15.00p in the past 12 months.
    What is IXICO PLC’s market cap?
    IXICO PLC’s market cap is £11.35M.
      When is IXICO PLC’s upcoming earnings report date?
      IXICO PLC’s upcoming earnings report date is Dec 03, 2025 which is in 123 days.
        How were IXICO PLC’s earnings last quarter?
        Currently, no data Available
        Is IXICO PLC overvalued?
        According to Wall Street analysts IXICO PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does IXICO PLC pay dividends?
          IXICO PLC does not currently pay dividends.
          What is IXICO PLC’s EPS estimate?
          IXICO PLC’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does IXICO PLC have?
          IXICO PLC has 92,668,594 shares outstanding.
            What happened to IXICO PLC’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of IXICO PLC?
            Currently, no hedge funds are holding shares in GB:IXI

            Company Description

            IXICO PLC

            IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, Netherlands, Ireland, rest of Europe, the United States, and internationally. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company's technologies comprise Assessa, a secure online digital platform that provides clinical decision support for patient selection and post-marketing surveillance; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer. Its focused therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis and other demyelinating diseases, Progressive Supranuclear Palsy, and other rare neurological diseases. The company also engages in the data collection, optimization, and analytics of rare neurological disorders; offers drug development analytics, imaging operation services, and post marketing surveillance services, as well as consultancy services; and provides end-to-end services, such as trail design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. IXICO plc was incorporated in 1995 and is based in London, the United Kingdom.

            IXICO plc (IXI) Earnings & Revenues

            Currently, no data available
            Please return soon. This page is being updated.
            Similar Stocks
            Company
            Price & Change
            Follow
            Oncimmune Holdings
            Oxford BioDynamics
            Cizzle Biotechnology Holdings PLC
            Fusion Antibodies Plc
            Aptamer Group Plc

            Ownership Overview

            1.41%98.59%
            Mutual Funds
            ― Other Institutional Investors
            98.59% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis